AstraZeneca Sees $4B In COVID-19 Vaccine Sales

AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time.

The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford.

Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research.

The Anglo-Swedish drugmaker said in November it would begin to take a “modest” profit from the COVID-19 shot, which it had been providing “at cost” — around $2 to $3 —following an agreement with Oxford. Other COVID-19 vaccine producers, such as Pfizer and Moderna, have been booking hefty profits on their shots all along.

Dr Tamara Joffe administer a dose of the AstraZeneca COVID-19 vaccine to Mustafa Field of the Faiths Forum, during a pilot project of pop up vaccination drive called Vaxi Taxi in Kilburn, London, Sunday, Feb. 28, 2021.  (AP Photo/Alastair Grant)

In the three months to September, the company said revenue jumped by about 50%, to a record $9.9 billion. The increase was due to sales of more than $1 billion in COVID-19 vaccines and the inclusion for the first time of some $1.3 billion worth of revenue from its rare disease business unit following the recent acquisition of Alexion.

Ticker Security Last Change Change %
AZN ASTRAZENECA PLC 59.24 +2.04 +3.58%

AstraZeneca forecast total group sales to rise by a “high teens percentage” in 2022, but said COVID-19 revenues would decline by a “a low-to-mid twenties percentage.”

Chief executive Pascal Soriot said AstraZeneca had “delivered on our promise of broad and equitable access to our COVID-19 vaccine with 2.5 billion doses released for supply around the world.”

“AstraZeneca continued on its strong growth trajectory in 2021, with industry-leading R&D (research and development) productivity, five of our medicines crossing new blockbuster thresholds, and the acquisition and integration of Alexion,” he said.

Soriot said the company would raise the dividend to shareholders by 10 cents to $2.90, the first increase in a decade.

AstraZeneca shares were trading about 3% higher at 8.62 pounds ($11.68) on the London Stock Exchange on Thursday morning.

Source: AstraZeneca sees $4B in COVID-19 vaccine sales | Fox Business

.

Critics:

AstraZeneca (AZN.L) said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the drugmaker is in talks with several countries about new orders for delivery next year.

AstraZeneca made a commitment to sell the shot developed with Oxford University at cost during the pandemic and in a press conference on Friday said low-income nations would continue to receive the vaccine on a no-profit basis, while a post-pandemic commercial approach would apply to other new orders even as infections in Europe rise again. read more

The Anglo-Swedish company’s third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14%. Total product sales jumped 49% to $9.74 billion, as its vaccine sales topped $1 billion.

“We started this project to help … but we also said that at some stage in the future, we will transition to commercial orders,” Chief Executive Pascal Soriot told journalists.”It will never be high priced. Because we want the vaccine to remain affordable to everybody around the world,” he added.

Soriot, a French national, said the virus was becoming endemic, a term for a background level of infections that is part of everyday life.Talks about new orders with undisclosed countries were underway, mainly for delivery next year, with some prospective customers focusing on booster shots, Soriot said.

AstraZeneca unveiled plans this week to set up a separate unit to focus on its coronavirus efforts and other respiratory infections. It said on Friday the unit would independently manage production and distribution. read more

Shares of the FTSE 100 (.FTSE) drugmaker were down 3.4% at about 91.22 pounds at 1209 GMT as overall third-quarter profit fell short of analysts’ expectations.

There were strong performances of core products like kidney disease treatment Farxiga and established asthma drug Symbicort, and from the addition of rare-disease specialist Alexion from July 21, thanks to last year’s $39 billion takeover deal.

However, integration costs related to that deal ate into profits, as did a $1.2 billion writedown for an experimental kidney disease drug AstraZeneca acquired in 2012, with overall expenses also rising on investments into the drug pipeline.

Top selling drug Tagrisso for lung cancer also posted lower-than-expected growth in sales due to price cuts in China. AstraZeneca said a profit boost from the vaccine in the fourth quarter would make up for costs related to its antibody cocktail for preventing and treating COVID-19, as it stuck with its earnings forecast for the year.

Related contents:

“AstraZeneca > GC Powerlist: Sweden Teams 2019”. http://www.legal500.com. Retrieved 30 December 2020.

UK “will be able to get out of this by the spring”, minister says after regulator approves AstraZeneca vaccine”. CNN. Retrieved 30 December 2020.

AstraZeneca’s COVID-19 vaccine gets the green light in the UK”. biopharma-reporter.com. Retrieved 30 December 2020.

“Registered office and corporate headquarters”. AstraZeneca. Retrieved 27 February 2020.

“A history of AstraZeneca”. pharmaphorum.com. 18 September 2020. Retrieved 31 March 2021.

“Global 500 – Pharmaceuticals”. Fortune. 20 July 2009. Archived from the original on 23 August 2010. Retrieved 19 August 2010.

“Key facts”. AstraZeneca. Archived from the original on 8 September 2010. Retrieved 1 September 2010.

 AstraZeneca to ax 1,600, relocate thousands in global R&D reshuffle”. fiercebiotech.com. FierceBiotech.

“Organizational Portraits – AstraZeneca”. The Pharmaceutical Century: Ten Decades of Drug Discovery. Washington, D.C.: ACS Publications. 17 November 2000. Retrieved 14 July 2008.

“Our History – AstraZeneca Careers”. AstraZeneca Careers.

“AstraZeneca Selects Wilmington, Del. for New US Headquarters”.

“AstraZeneca’s Iressa FDA committee judgement expected tomorrow”. 23 September 2002. Retrieved 7 July 2013.

“ZI is dripping with promise”. Archived from the original on 11 June 2014.

AstraZeneca buys biotech company for £120m The Telegraph, 23 December 2005

AstraZeneca and Astex ally for anticancer agents Business Intelligence, 1 July 2005

“Pennsylvania Bio – Member Listings”. Pennsylvania Bio web site. Archived from the original on 14 December 2005. Retrieved 8 October 2005.

AstraZeneca agrees to buy Arrow Therapeutics for US$150M Marketwatch, 1 February 2007

AstraZeneca seeks a remedy for its patent pain The Telegraph, 21 April 2012

“AstraZeneca to pay $15.2B to purchase rival MedImmune; Deal sees London-based drugmaker take on debt for the first time in order to fill product line”. Bloomberg.

AstraZeneca Buys MedImmune for US$ 15.6 Billion The New York Times, 24 April 2007

“AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories”. 23 December 2009. Retrieved 20 February 2015.

“Novexel to be Acquired by AstraZeneca”. Retrieved 20 February 2015.

AstraZeneca to buy Chinese generics firm Healthcare News, 8 December 2011

AstraZeneca and Amgen collaborate on treatments for inflammatory diseases Medcity News, 4 February 2012

AstraZeneca Reaches $1.26 Billion Deal for Ardea Biosciences The New York Times, 23 April 2012

Peacock, Louisa (30 June 2012). “AstraZeneca to pay £2.2bn towards ‘joint venture’ diabetes deal”. The Daily Telegraph. London. Archived from the original on 4 August 2012. Retrieved 1 July 2012.

Moderna Data Shows mRNA Isn’t a Quick Fix For The Flu Vaccine

The first data from clinical trials of Moderna’s mRNA-based seasonal flu vaccine, released by the company Friday morning, were underwhelming — a finding that shows gene-based vaccines might not be a fix for all the problems with vaccine development.

The overwhelming success of the mRNA COVID-19 vaccines, made by Moderna and Pfizer / BioNTech, supercharged interest in that strategy for developing shots. The shots inject people with tiny snippets of the gene for a virus, which the body builds and then uses to learn how to fight the virus.

Current flu shots contain inactivated copies of the influenza virus. mRNA vaccines are faster to design and produce because manufacturers don’t have to grow copies of the virus, which is why experts have for years seen them as the future of vaccines.

Moderna launched a clinical trial of an mRNA seasonal flu vaccine this summer, hoping to capture the same success as it did with its COVID-19 vaccine. Typically, seasonal flu shots are around 40 to 60 percent effective, and pharmaceutical companies want to make that better. Three other companies are also working on mRNA flu shots.

Moderna released its first results during an investor phone call and presented slides showing that the mRNA flu shots did generate antibodies — but the levels of those antibodies weren’t higher than those for other flu shots already on the market. They also had more side effects than existing shots.

The findings don’t necessarily mean that mRNA flu shots aren’t any better than what we have now. Because mRNA vaccines are faster to design and make, the shots don’t have to be developed as far in advance. Companies may not have to do as much guesswork around what strain of the flu to target them against each year because they can wait to make the shots until they see what strains are circulating.

And as far as efficacy goes, there’s still a lot more data to collect: Moderna is preparing to conduct larger trials that would test how well the shots actually keep people from getting sick in the real world (not just testing antibody levels)..

Still, this early data shows that the immune system is tricky and that mRNA vaccines probably aren’t an easy shortcut for stopping a virus as persistent as the flu. More studies will be needed to figure out if there is a specific benefit to using mRNA vaccines to fight the flu, wrote chemist and writer Derek Lowe in Science. But it’s not a sure thing.

Nicole Wetsman

Source: Moderna data shows mRNA isn’t a quick fix for the flu vaccine – The Verge

.

More contents:

Regeneron Says Antibody Therapy Prevents COVID-19 Infections

Regeneron Pharmaceuticals is planning to ask the Food and Drug Administration (FDA) to allow its antibody cocktail to be used as a preventive treatment for COVID-19, the company said Monday.

New results from a clinical trial conducted with the National Institute of Allergy and Infectious Diseases found the drug reduced the risk of symptomatic infection by 81 percent in people who were not infected at the start of the trial, Regeneron said.

The company has already received emergency use authorization from the FDA to use its antibody drugs to treat adults with mild to moderate COVID-19 and pediatric patients at least 12 years old who have tested positive for the virus and are at high risk of severe disease but are not yet hospitalized.

The trial enrolled 1,505 people who were not infected with the virus but lived in the same household as someone who recently tested positive. The patients were randomized to receive either one dose of the antibody therapy or a placebo administered as injections.

After 29 days, 11 people out of the 753 who received a single 1,200 mg dose of the treatment developed symptomatic COVID-19; 59 people who received a placebo out of 752 participants developed symptomatic COVID-19.

The drug provided 72 percent protection against symptomatic infections in the first week and 93 percent protection in subsequent weeks, Regeneron said. The data has not yet been peer reviewed or published.

Regeneron also said the trial found individuals treated with the therapy who experienced a symptomatic infection resolved their symptoms in one week, compared to three weeks with placebo. Infected individuals also cleared the virus faster with the therapy, the company said.

Adverse events occurred in 20 percent of patients who received the antibody drug and 29 percent of those who received a placebo, Regeneron said, but nobody withdrew from the trial because of them.

None of the participants who received the therapy were hospitalized or went to the ER because of COVID-19 over the course of 29 days; four in the placebo group did so. There were four deaths in the trial — two in the therapy group and two in the placebo group — but none were reported due to COVID-19 or the drug.

“With more than 60,000 Americans continuing to be diagnosed with COVID-19 every day, the REGEN-COV antibody cocktail may help provide immediate protection to unvaccinated people who are exposed to the virus, and we are also working to understand its potential to provide ongoing protection for immunocompromised patients who may not respond well to vaccines,” George Yancopoulos, president and chief scientific officer at Regeneron, said in a statement.

The trial tested the antibody treatment for use as a “passive vaccine,” which involves directly injecting antibodies into the body. Traditional vaccines rely on a person’s immune system to activate and develop its own antibodies.

That means the treatment may provide immediate benefits, in contrast to active vaccines, which take weeks to provide protection. In addition, using injections rather than an infusion could make administering it more convenient than the currently authorized use for antibody drugs.

While much of the attention has been focused on vaccines, experts say therapeutic treatments are just as important to ending the pandemic, which has killed more than 562,000 Americans.

Source: Regeneron says antibody therapy prevents COVID-19 infections | TheHill

.

.

The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work

Remdesivir in a syringe.

While clinical trials suggest remdesivir isn’t very effective in treating Covid-19, recent studies have shown that it does block Coronavirus activity. That apparent contradiction makes the antiviral drug even more controversial.

Remdesivir is an experimental drug developed by biotech company Gilead Sciences (under the brand name Veklury) in collaboration with the US Centers for Disease Control and Army Medical Research Institute of Infectious Diseases.

It’s one of many drug candidates that were originally designed in response to the threat from emerging diseases caused by RNA viruses — germs like the one behind the 2002 SARS outbreak — that have potential to cause global pandemics.

Such ‘broad-spectrum’ drugs target features shared by a wide range of disease-causing germs. In remdesivir’s case, that’s the virus’ genetic material, RNA. The drug proved ineffective against the Ebola virus, however, yet was still subsequently repurposed for SARS-CoV-2 coronavirus.

Remdesivir is not effective for Covid

News media prematurely reported that patients were responding to treatment. But the published data lated showed that “remdesivir was not associated with statistically significant clinical benefits [and] the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.”

.

.

As our special series On the Front Lines continues, NBC’s Joe Fryer profiles one of the country’s first COVID-19 patients, Raymond Sismaet, who spent nearly a month in a hospital before recovering. His story spotlights the antiviral drug remdesivir as a possible coronavirus treatment. » Subscribe to TODAY: http://on.today.com/SubscribeToTODAY » Watch the latest from TODAY: http://bit.ly/LatestTODAY About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day.
If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. Connect with TODAY Online! Visit TODAY’s Website: http://on.today.com/ReadTODAY Find TODAY on Facebook: http://on.today.com/LikeTODAY Follow TODAY on Twitter: http://on.today.com/FollowTODAY Follow TODAY on Instagram: http://on.today.com/InstaTODAY Follow TODAY on Pinterest: http://on.today.com/PinTODAY #Coronavirus #Remdesivir #TodayShow

.

.

The controversy surrounding remdesivir therefore revolves around whether the drug is actually an effective treatment. Early studies produced conflicting evidence on remdesivir’s effectiveness. Some found that Covid patients who received the drug recovered faster and fewer people died, but other studies showed that it didn’t reduce the length of hospitalization or death rate.

What’s weird about remdesivir is that it hasn’t been held to the same standards as other drug candidates. Covid-19 vaccines have been developed 10 times faster than traditional drugs, but they’ve passed the phase-3 clinical trials that test whether a potential medicine is both safe and effective in thousands of people.

Normally, a drug is only approved for use by a regulatory body like the US Food and Drug Administration if it meets the two criteria for safety and efficacy. Nonetheless, in October 2020, remdesivir was granted approval by FDA based on promising data from relatively small trials with about 1000 participants.

A large-scale analysis by the World Health Organization’s Solidarity trial consortium has cleared-up the confusion. Based on interim results from studying more than 5000 participants, the international study concluded that remdesivir “had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay.”

As a consequence of being mostly ineffective, WHO recommends against the use of remdesivir in Covid-19 patients.

Remdesivir is an expensive drug

The drug is administered over 5 or 10 days. A five-day course of treatment costs around $2600 per person. So for a hospital with hundreds of Covid patients, that would amount to millions of dollars for one antiviral.

That price could be cost-effective if remdesivir saved lives and its use was limited to moderate or severe disease, but it’s also being made available for milder cases and WHO found that it isn’t a lifesaving drug.

What next for remdesivir? Following WHO’s finding, an article in the British Medical Journal highlighted another antiviral as a cautionary tale: oseltamivir or ‘Tamiflu’ — a drug that aims to block the influenza virus.

During the early 2000s, governments started stockpiling Tamiflu, paying billions to its manufacturer, pharmaceutical firm Roche. Then in 2013, independent researchers gained access to Roche’s unpublished data, revealing that the drug caused many side effects and only shortened the duration of flu symptoms by a few hours.

Tamiflu only cost $75 per treatment and yet was still a massive waste of money. The BMJ article implies that the story of remdesivir is another scandal waiting to happen.

Given that remdesivir is expensive and doesn’t seem to save lives, does it have any value? Maybe — but not as a medicine itself. Recent research suggests scientists should at least keep studying how it works in order to develop better drugs.

Remdesivir does block Coronavirus

Remdesivir doesn’t prevent people from being infected by the SARS-CoV-2 virus.

Whereas a vaccine is designed prompt your immune system to recognize the spike protein that allows Coronavirus to invade cells — and protect people from infection — antivirals such as remdesivir aim to disrupt the virus’ ability to replicate, to slow its spread and give your body extra time to develop immunity.

Coronaviruses use RNA for their genetic material — not the DNA used by cells — which means that they need a special molecular machine to copy their genes when producing new virus particles. That machine, ‘RNA polymerase’, is what’s targeted by remdesivir.

Two studies have now revealed how remdesivir blocks SARS-CoV-2 at the molecular level.

First, chemical engineers at the University of Chicago found that remdesivir is better at reducing virus replication than two similar antivirals, ribavirin and favilavir. Their computer models suggest that remdesivir beats the other drugs because it’s the best at binding and destabilizing the RNA polymerase.

In the second new study, researchers at the University of Texas at Austin used ‘cryogenic-electron microscopy’ (cryo-EM) to take snapshots of the structure of the molecules involved in replication as they would interact in a Covid patient.

After adding remdesivir to RNA polymerase, cryo-EM images showed that the drug acts like a blockage in a photocopier, getting stuck in the RNA polymerase. When four molecules of remdesivir get between the gears of the polymerase machine, its copies of RNA ‘paper’ can no longer pass through, stalling the virus-copying process.

That leads us to why it’s worth studying remdesivir. As structural biologist David Taylor explains, “We were able to identify the point where that paper jam happens […] If we want to make the blockage even worse, we could do so.”

One of remdesivir’s flaws is its (possibly toxic) high dosage over a short timeframe, which contributes to adverse side effects. By tweaking the drug molecule’s structure, scientists may be able to make it block the RNA polymerase machine with fewer molecules, which would then allow the drug to be delivered in a smaller dose.

In fact, Gilead Sciences has already isolated a compound similar to remdesivir, GS-441524, which costs less and is easier to manufacture. It’s also simpler to administer: while remdesivir must be injected, GS-441524 could be ingested in pill form. More of the molecule reaches the lungs — the main site of infection — too, which led researchers to state that “GS-441524 is superior to remdesivir for Covid-19 treatment.”

As SARS-CoV-2’s genetic material mutates to create new strains of the virus — and variants of Covid-19 — we may need antivirals to buy us time if those new strains end-up evading our current vaccines.

So despite being expensive and ineffective at treating Covid, remdesivir’s true value could be to help researchers create more effective medicines.

Follow me on Twitter or LinkedIn. Check out my website or some of my other work here.

I’m a science communicator specialising in public engagement and outreach through entertainment, focusing on popular culture. I have a PhD in evolutionary biology and spent several years at BBC Science Focus magazine, running the features section and writing about everything from gay genes and internet memes to the science of death and origin of life. I’ve also contributed to Scientific American and Men’s Health. My latest book is ’50 Biology Ideas You Really Need to Know’

Source: The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work

.

.

More Contents:

Hospitals to provide Remdesivir to patients in Pune: official | Health
[…] Owing to the shortage of Remdesivir injections in Pune city, the administration has issued a notification stating that the drug wil […] Authorities have also started a new helpline for those who need Remdesivir […]
0
Delhi govt bans all gatherings except marriages & funerals till 30th April
newsonair.com – Today
[…] over 10 crore doses of COVID-19 vaccine in 85 days            Centre prohibits exports of injection Remdesivir & Active Pharmaceutical Ingredients of Remdesivir            Delhi govt bans all gatherings except marriages & funerals till 30th April           […]
0
CBI books former TMC MP for fraud : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
1
Remdesivir to be available for those in need: Nanded collector | Politics
Nanded has received 1,589 vials of Remdesivir, a key medicine in COVID-19 treatment, on Saturday and another 400 will arrive on Sunday, th […] There is a shortage of Remdesivir but efforts were on to tide over it, and a committee under the additional collector has been formed […]
0
COVID-19 in Chhattisgarh: Amid massive surge in cases, here’s what state Health Minister TS Singh Deo has to say about covid situation in state
[…] What is the status of vaccination and Remdesivir? Our vaccine stock will last for 2-3 days only. Meanwhile, we are running short of the Remdesivir antiviral vaccine and require immediate supply of the vaccine […]
0
Won’t allow Guru Teg Bahadur’s statue in Delhi, Sikh bodies tell Centre : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
12
Have only 5 days of vaccine left, Punjab CM tells Sonia at Covid review meet : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
6
Lockdown not a solution to deal with Covid-19: Arvind Kejriwal | IndiaToday
[…] reports 10,250 new Covid cases in 24 hours Sun, 11 Apr, 2021 Centre halts export of anti-viral drug Remdesivir amid surge in Covid cases Sun, 11 Apr, 2021 Yogi Adityanath on battling second Covid wave […]
12
India bans export of COVID-19 treatment drug remdesivir
medicalxpress.com – Today
India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for th […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […] generic pharmaceutical producers based in India, Pakistan and Egypt, allowing them to manufacture remdesivir for distribution in 127 mostly low and lower-middle income nations […] Seven firms in India—the world’s biggest producer of generic drugs—are licensed to manufacture remdesivir […]
2
Day before procurement starts, trucks carrying illegal wheat from Bihar found in Bathinda : The Tribune India
[…] 3 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
58
RTPCR negative report mandatory for those coming to Chhattisgarh by rail, air route: CM Baghel instructs officials | Law-Order
[…] He has instructed the Chief Secretary that for smooth supply of Remdesivir injection in the state, senior officers should be sent to Hyderabad and Maharashtra fo […] this issue with the President of the Drug Association and asked him to increase the supply of Remdesivir Injection from other states […]
0
Lockdown Needed, But Decision After Wednesday: Maharashtra Minister Rajesh Tope
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […] in a meeting with the State Task Force discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
16
India finalises air bubble pact with Sri Lanka: Ministry : The Tribune India
[…] 3 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
1
Maha CM discusses strengthening of health infra with task force | Health
[…] plants, upgrading the number of beds and other medical facilities, besides availability of Remdesivir injections in a meeting held with members of the state COVID-19 task force […] The meeting also discussed how to stop the ”irrational use” of Remdesivir drug, which is in high demand for the treatment of COVID-19 patients […]
0
Maharashtra Covid task force feels ‘lockdown is required’, but decision only after 14 April
theprint.in – Today
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
N/A
Coronavirus latest news: South Africa variant can ‘break through’ Pfizer’s vaccine
[…] 4:46pm India bans export of Covid-19 treatment drug remdesivir India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand fo […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […]
N/A
Headlines now: Centre flags gaps in Covid containment measures of 3 states, and other top news
scroll.in – Today
[…] Centre bans export of antiviral drug Remdesivir amid surge in cases: The government said the ban will be in place till the Covid-19 situation i […]
1
Experts demand generic version of drug effective against Covid-19
[…] Among the medicines that have shown to work in Covid-19 are steroids and Remdesivir. The patent owner of Remdesivir, Gilead, had given voluntary licence to six Indian pharmaceuticals […] on rationalising the use of Remedesivir with strict adherence to the guidelines, making multiple Remdesivir stores or Remdesivir banks with strict sales control, and making racketeering of Remdesivir punishable under the Epidemic Act of India […]
1
Decision on Maharashtra lockdown after April 14: State Health Minister | Business Standard News
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
N/A
Enterprise Information | Inventory and Share Market Information – Information by Automobilnews.eu
automobilnews.eu – Today
The Centre has taken the step at a time when the nation is seeing a rising demand for Remdesivir injections attributable to a steep rise in COVID-19 circumstances within the wake of the secon […]
N/A
Nitin Gadkari calls up Sun Pharma’s chief to arrange Remdesivir injections for Nagpur | Indiablooms – First Portal on Digital News Management
[…] today Nitin Gadkari Image: PIB Nitin Gadkari calls up Sun Pharma’s chief to arrange Remdesivir injections for Nagpur India Blooms News Service | @indiablooms | 11 Apr 2021, 07:55 p […] India Blooms News Service | @indiablooms | 11 Apr 2021, 07:55 pm #NitinGadkari, #SunPharma, # Remdesivir, #Nagpur Nagpur/UNI: Union Minister Nitin Gadkari called up Sun Pharma’s chief to arrange fo […] With Maharashtra witnessing a spurt in COVID-19 cases, Remdesivir injections are in high demand in the state. Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patient […]
0
Remdesivir Shortage In Nagpur; Gadkari Dials Sun Pharma Chief
Remdesivir [Image: Reuters] Union minister Nitin Gadkari has called up Sun Pharma’s chief to arrange fo […] Union minister Nitin Gadkari has called up Sun Pharma’s chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra. Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patient […] over phone to inform him about the situation here and appealed to him to make available the Remdesivir injections […]
6
Appropriate decision on lockdown in Maha after April 14: Tope | Politics
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
0
India bans remdesivir exports as COVID-19 cases surge | India News | Al Jazeera
India has banned the export of antiviral drug remdesivir and its active pharmaceutical ingredients as demand rocketed amid a record surge in COVID-1 […] In addition to the remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] The World Health Organization in November issued a conditional recommendation against the use of remdesivir on hospitalised patients, regardless of disease severity, saying there was no evidence that th […]
13
India at third spot on Forbes billionaires’ list : The Tribune India
[…] 2 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
4
India bans export of Covid-19 treatment drug remdesivir
India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for th […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […] generic pharmaceutical producers based in India, Pakistan and Egypt, allowing them to manufacture remdesivir for distribution in 127 mostly low and lower-middle income nations […] firms in India — the world’s biggest producer of generic drugs — are licensed to manufacture remdesivir […]
N/A
Lack of testing, Covid appropriate behaviour not being followed in three states, says Centre
scroll.in – Today
[…] “Similarly, shortage of Remdesivir, Low Molecular Weight Heparin needs urgent attention in Korba District,” the central governmen […]
1
India bans exports of Remdesivir drug as new COVID-19 cases hit another record
thefinancialexpress.com.bd – Today
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
1
Centre bans exports of anti-viral drug Remdesivir
[…] The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves […] In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the statement said […] The government has taken the following steps to ensure easy access of hospital and patients to Remdesivir: 1. All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
2
SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
starpharma.com – Today
[…] very favourably with the selectivity index against SARS-CoV-2 reported in the literature of 279 for remdesivir and 55 for hydroxychloroquine […]
13
India bans Remdesivir exports as coronavirus rages on; rallies continue | MarketScreener
[…] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients, saying there was no evidence that the drug improved survival and othe […]
N/A
India bans Remdesivir exports as coronavirus rages on; rallies continue | Health
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients, saying there was no evidence that the drug improved survival and othe […]
0
Maharashtra: Decision on Covid lockdown after 14 April, says health minister Tope
The Maharashtra CM discussed several issues including availability of beds, use of Remdesivir and imposition of restrictions in today’s meeting The worst-hit Covid-19 state has administered over 1 crore vaccine doses state so far
7
India bans export of anti-viral drug Remdesivir amid surge in Covid cases
inquest.org.in – Today
[…] In the order, the government said it has banned the export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] To ensure more people can get Remdesivir, the government said manufacturers of Remdesivir have been asked to show on their website the details of their stockists and distributors […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir,” the government said. The National Clinical Management Protocol for COVID-19 lists Remdesivir as an investigational therapy, where informed and shared decision making is essential […]
5
India bans exports of antiviral drug Remdesivir as COVID-19 cases surge
NEW DELHI: India on Sunday (Apr 11) banned the export of antiviral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
N/A
Coronavirus Lockdown India News Live Updates: Covid-19 Cases, Lockdown, Night Curfew Guidelines in Delhi, UP, Maharashtra, MP Today Latest News
indianexpress.com – Today
[…] As Covid-19 cases continued to surge, Centre on Sunday banned the export of anti-viral drug remdesivir in view of increased demand, news agency PTI reported […] easy access of the drug, which is used in treatment of coronavirus, all domestic manufacturers of remdesivir have been requested to display details of their stockists and distributors on their website, th […] 13:52 (IST) 11 APR 2021 Two including nurse arrested for illegal Remdesivir sale The Crime Branch of Pune City police has arrested two persons, including a nurse from […]
3
Covid-appropriate behaviour not being followed in three states: Govt | Business Standard News
[…] Shortage of Remdesivir and low molecular weight Heparin needs urgent attention in Korba, the ministry said […]
1
Govt bans export of Remdesivir: Know all about the drug
[…] What is Remdesivir? Remdesivir is an investigational antiviral drug to fight Sars-cov 2, the virus that causes Covid-19 […] How did Remdesivir come into use? FDA had to issue an emergency use authorisation of Remdesivir to give doctors access to the medication outside of an investigational (clinical trial) setting […]
N/A
COVID appropriate behaviour not being followed in 50 most-affected districts in 3 states: Govt | Health
[…] Shortage of Remdesivir and low molecular weight Heparin needs urgent attention in Korba, the ministry said […]
0
Govt prohibits exports of remdesivir till COVID situation improves in India | India News,
indianexpress.com – Today
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injectio […] which is used in treatment of coronavirus, to hospitals and patients, all domestic manufacturers of remdesivir have been advised to display on their website details of their stockists and distributors, th […] This has led to a sudden spike in demand for remdesivir injection used in treatment of COVID patients,” the ministry said […] “In light of the above, Government of India has prohibited the exports of remdesivir injection and remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” it said […]
10
Mathura’s Banke Bihari temple issues new guidelines amid surge in COVID-19 cases | India News • eeKPe News
news.eekpe.com – Today
[…] As India experiences a second wave of novel coronavirus infections, the demand for anti-viral drug Remdesivir has surged too. The Centre on… Read more India Bans Export Of Anti-Viral Drug Remdesivir Amid Surge In… INDIA eekpe – April 11, 2021 0 <!– –>7 Indian corporations are producing Remdesivir beneath voluntary licensing settlement with Gilead Sciences (File)New Delhi: India has banne […]
0
Doctors continue debate over ivermectin for COVID-19
[…] that only 16 deaths have been reported involving ivermectin, compared to much higher totals for remdesivir, which is used to treat COVID-19 symptoms, as well as COVID-19 vaccines […]
24
Can natural antioxidants help fight new GI symptoms in Covid patients?
yespunjab.com – Today
[…] (Agency) Covid Spike: India Prohibits Export Of Remdesivir – Advertisement – ShareFacebook Twitter Pinterest WhatsApp Linkedin Telegram Yes Punjab – TO […]
1
Covid spike: India prohibits export of remdesivir
[…] trend, the Ministry said: “There is a potential of further increase in demand of injection remdesivir and remdesivir active pharmaceutical ingredients (API) in the coming days […] of the above increasing Covid cases, Government of India has prohibited the exports of injection remdesivir and remdesivir active pharmaceutical ingredients (API) till the situation improves […] ” Govt of India prohibited exports of injection remdesivir and active pharmaceutical ingredients Seven Indian companies are producing injection remdesivir under voluntary licensing agreement with Gilead Sciences, US […]
0
India bans exports of anti-viral drug Remdesivir as Covid-19 cases surge
kathmandupost.com – Today
India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in Covid-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
0
India bans exports of Remdesivir drug as new Covid-19 cases hit another record, South Asia News & Top Stories
NEW DELHI (REUTERS) – India on Sunday (April 11) banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in Covid-1 […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for Covid-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,”Mr Rajesh Tope, health minister of India’ […]
3
India bans exports of Remdesivir drug as new Covid-19 cases hit another record
NEW DELHI (REUTERS) – India on Sunday (April 11) banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in Covid-1 […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for Covid-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,”Mr Rajesh Tope, health minister of India’ […]
1
Centre prohibits export of Injection Remdesivir in view of surge in COVID cases
[…] This has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients […] In light of the above, the Government of India has prohibited the export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves […] Government of India has taken the following steps to ensure easy access of hospital and patients to Remdesivir: All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
1
Vaccine universalisation, vaccine nationalism need of the hour: AAP leader Chadha writes to PM | Politics
[…] for all and taking steps like prohibiting COVID medicine export as it has today banned export of remdesivir injections,” he said […]
0
India bans export of Remdesivir amid rising Covid-19 cases
newsvibesofindia.com – Today
New Delhi (NVI): India has prohibited exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation improves, as the countr […] It said that there is a potential of further increase in the demand of Injection Remdesivir in the coming days. At present, seven Indian companies are producing Injection Remdesivir under voluntary licensing agreement with M/s […] In light of the above, India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves, the Ministry said […]
0
Maharashtra: Thane Covid centre patients shifted over oxygen concerns | Business Standard News
[…] as officer in charge to coordinate the purchase, storage and distribution of medical oxygen gas and Remdesivir injections, a release by civic spokesperson Sandeep Malavali said […]
N/A
India bans exports of Remdesivir drug as new COVID-19 cases hit another record | MarketScreener
[…] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
N/A
Maha: Thane COVID centre patients shifted over oxygen concerns | Health
[…] as officer in charge to coordinate the purchase, storage and distribution of medical oxygen gas and Remdesivir injections, a release by civic spokesperson Sandeep Malavali said […]
0
India Bans Exports of Antiviral Drug Remdesivir as COVID-19 Cases Surge
science.thewire.in – Today
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month.
2
India bans exports of Remdesivir drug as new COVID-19 cases hit another record | Health
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
0
Amidst sharp rise in COVID-19 cases, India bans export of Remdesivir; its active pharmaceutical ingredients
asianews.press – Today
[…] As a result, it has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients and the potential for a further increase in this demand i […] The Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) “till the situation improves in the country […] India govt has taken the following steps to ensure easy access of hospital and patients to Remdesivir: All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
1
No export of Remdesivir till COVID situation improves in India: Govt
New Delhi: In view of increased demand for Remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injectio […] which is used in treatment of coronavirus, to hospitals and patients, all domestic manufacturers of Remdesivir have been advised to display on their website details of their stockists and distributors, th […] This has led to a sudden spike in demand for Remdesivir injection used in treatment of COVID patients,” the ministry said […] “In light of the above, Government of India has prohibited the exports of remdesivir injection and remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” it said […]
0
India halts export of key Covid drug Remdesivir as cases rise across country
theprint.in – Today
Text Size: A- A+ New Delhi: The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves. Remdesivir is considered a key anti-viral drug in the fight against Covid-19 […] addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir. All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
N/A
Enterprise Information | Inventory and Share Market Information – Information by Automobilnews.eu
automobilnews.eu – Today
“Export of injection Remdesivir and Remdesivir Energetic Pharmaceutical Components (API) prohibited until the COVID-19 state of affairs within the […]
N/A
As coronavirus cases spike, Indore’s health infrastructure gets stretched | Business Standard News
[…] uploading videos and messages on social media about shortage of beds and key medicines like Remdesivir […] He said Remdesivir consignments were coming in at present and their distribution was taking place as per guidelines […] “Doctors have been told to give Remdesivir injections only to those who absolutely need it,” Satya said […]
2
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves,” the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalized patients, saying there was no evidence that the drug improved survival and othe […]
10
Covid-19: India bans export of Remdesivir injection, API
India today prohibited the export of Remdesivir injection, which is used to treat Covid patients, and also Remdesivir Active Pharmaceutical Ingredients (API), amidst a surge in coronavirus cases in the country […] “This has led to a sudden spike in the demand for injection Remdesivir used in treatment of Covid patients […] Seven Indian companies are producing the Remdesivir injection under voluntary licensing agreement with M/S Gilead Sciences of the USA […]
3
Maharashtra likely to announce 15-day lockdown after weekend curbs, marginal drop in Covid-19 cases after night curfew
[…] Other suggestions by Fadnavis like the early report of tests, availability of Remdesivir and oxygen for treatment will also be considered […]
1
“For God’s Sake, Get Vaccine, Drugs”: Top Mumbai Doctor’s Desperate Appeal
[…] The hospital was not only short of vaccines but also life-saving drugs like Remdesivir, said Dr Jalil Parkar, a pulmonary consultant with the hospital […] There is a shortage of Remdesivir, there is shortage of Tosilizubam […] “My earnest request for god’s sake please see to it that Remdesivir, Tosilizubam, vaccination — they are available […]
0
COVID-19: Centre bans exports of anti-viral drug Remdesivir till situation in India improves
COVID-19: Centre bans exports of anti-viral drug Remdesivir till situation in India improves India’s sudden spike in COVID-19 cases has led to an increase i […] Zee Media Updated: Apr 11, 2021, 06:29 PM IST The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves […] data on deaths In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the statement said […]
1
8k Remdesivir vials have arrived: Madhya Pradesh official as cases surge
[…] (Representational image: IE) Amid a surge in coronavirus cases and a clamour for Remdesivir, a drug considered useful in the treatment of the infection, a senior Madhya Pradesh official o […]
1
India bans Remdesivir exports till COVID surge abates
Seven Indian companies producing Remdesivir injections under voluntary licensing agreement with US-based Gilead Sciences have an installed capacity of about 38.80 lakh units per month
2
Government Halts Export Of Remdesivir Till COVID-19 Situation Improves
[…] The Government of India said: “Export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) prohibited till the COVID-19 situation in the countr […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir in India. Notably, there are seven Indian companies that are currently producing injection Remdesivir under voluntary licensing agreement with M/s Gilead Sciences, USA […]
6
Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. | Newsalert
Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. PTI | New Delhi | Updated: 11-04-2021 18:11 IST | Created: 11-04-2021 18:11 IST Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. (This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.) POST / READ COMMENTS Country India Share
0
Clinical Research Forum Presents Moderna and Pfizer with Award for Extraordinary Impact on Health | NEWS-Line for Healthcare Professionals
[…] Hospital; Margaret Lippincott, MD, Instructor in Medicine, Massachusetts General Hospital · Remdesivir in COVID 19 – John Beigel, MD, Associate Director for Clinical Research, National Institute o […]
1
Centre bans export of Remdesivir amid crunch, eases access of Covid patients to anti-viral drug – Coronavirus Outbreak News
[…] being used in the treatment of Covid-19 patients, the Centre has prohibited the export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) […] In a press note on Sunday, the Centre prohibited exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API). A number of companies in India produce Injection Remdesivir under a voluntary licensing agreement with US pharma giant Gilead Sciences […]
3
For God’s Sake, Get Vaccine, Drugs: Top Mumbai Doctor’s Desperate Appeal
[…] The hospital was not only short of vaccines but also life-saving drugs like Remdesivir, said Dr Jalil Parkar, a pulmonary consultant with the hospital […] There is a shortage of Remdesivir, there is shortage of Tosilizubam […] “My earnest request for god’s sake please see to it that Remdesivir, Tosilizubam, vaccination — they are available […]
16
Government bans export of Remdesivir till Covid-19 situation improves
economictimes.indiatimes.com – Today
[…] In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] the government has also taken a few steps to ensure easy access of hospital and patients to Remdesivir. These steps are: – All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
6
COVID-19: India bans export of Remdesivir drug, injection as coronavirus cases surge | India News
zeenews.india.com – Today
CORONAVIRUS COVID-19: India bans export of Remdesivir drug, injection as coronavirus cases surge The Centre banned the export of Remdesivir and its active pharmaceutical ingredients as the demand for anti-viral drug Remdesivir has surged […] As India experiences a second wave of novel coronavirus infections, the demand for anti-viral drug Remdesivir has surged too. The Centre on Sunday (April 11, 2021) banned the export of Remdesivir and its active pharmaceutical ingredients […]
16
India bans export of Remdesivir, its ingredients till COVID situation improves | Coronavirus News | Inshorts
inshorts.com – Today
india has banned the export of injection remdesivir and its active pharmaceutical ingredients api till the coronavirus situation in the country improves the centre said on sunday theres potential for further increase in demand for remdesivir in the coming days the government said adding that the …
0
Centre Bans Export of Remdesivir and Its Active Ingredients till Covid Crisis Eases in India
The Centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the pandemic situation arising ou […] The decision has been taken to ensure easy access of Remdesivir to infected patients and hospitals providing treating against the virus […] Several hospitals have complained of shortage of Remdesivir, considered a key anti-viral drug in the fight against COVID-19, especially in adult patients wit […] other steps to bring the situation under control, including advising all domestic manufactures of Remdesivir to display on their website, details of their stockists and distributors to facilitate access t […]
N/A
India bans export of Remdesivir injection amid surge in Covid cases | India News – Times of India
NEW DELHI: India on Sunday banned the export of Remdesivir injection till the Covid-19 situation improves in the country […] The government in a statement said that all domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir […] The alarming spike in Covid cases in the country has led to a sudden increase in demand for the Remdesivir injection used in treating Covid patients […]
0
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
NEW DELHI: India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
0
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge | Reuters
[…] 1 MIN READ NEW DELHI (Reuters) – India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
2
India bans export of Remdesivir injection amid surge in Covid cases | India News – Times of India
timesofindia.indiatimes.com – Today
India News: NEW DELHI: India on Sunday banned the export of Remdesivir injection till the Covid-19 situation improves in the country.
19
No lockdown in Madhya Pradesh, only ‘corona curfew’, says CM | Business Standard News
[…] We have received 4,000 injections of Remdesivir (the key anti-viral drug) and would be getting 5,000 more today […]
N/A
Coronavirus: Centre bans export of antiviral drug Remdesivir amid surge in cases
scroll.in – Today
The Centre on Sunday banned the export of antiviral drug Remdesivir indefinitely, in view of the rising coronavirus cases in the country, ANI reported […] The government said the ban, which covers Remdesivir injections and Remdesivir active pharmaceutical ingredients, will be lifted only after there is an improvement in th […] Remdesivir is considered a key drug in combating Covid-19, especially in adult patients with sever […]
1
Gilead Sciences : India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge | MarketScreener
“In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a statement. Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month. (Reporting by Krishna N. Das and Devjyot Ghoshal; Editing by Susan Fenton)
0
Centre Prohibits Export of Remdesivir till COVID-19 Situation in Country Improves
Centre Prohibits Export of Remdesivir till COVID-19 Situation in Country Improves…
1
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
mumbaimirror.indiatimes.com – Today
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge Reuters / Updated: Apr 11, 2021, 17:50 IST Representational Image […] Photo: BCCL New Delhi: India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
7
Centre prohibits export of Remdesivir & its API till COVID-19 situation improves in India
With several states complaining of shortage of Remdesivir injections – which is used in COVID-19 treatment, the Centre on Sunday, has banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation in the country improves […] READ | Remdesivir shortage in Nagpur; Union Minister Nitin Gadkari dials Sun Pharma chief Govt bans export of Remdesivir Additionally, Centre has taken the following steps to streamline Remdesivir supply: All domestic manufactures of Remdesivir have been advised to display on their website […]
15
Govt suspends export of Remdesivir till coronavirus situation improves | Business Standard News
The union government on Sunday suspended the export of Remdesivir injections and Remdesivir Active Pharmaceutical Ingredients (API) till the coronavirus situation improves in the country […] “The current situation has led to a sudden spike in demand for Remdesivir injection used in treatment of Covid patients […] In addition, the government has taken the steps to ensure easy access of hospital and patients to Remdesivir All domestic manufactures of Remdesivir have been advised to display on their website, details of their stock lists or distributors t […]
2
India bans export of Remdesivir drug, injection till Covid situation improves
“Export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) prohibited till the COVID-19 situation in the countr […] This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of a further increase in demand for Remdesivir injection in the coming days,” the Centre said in a statement […] of Pharmaceuticals has been in contact with domestic manufacturers to ramp up the production of Remdesivir, it further stated. In its fresh order, it said that all domestic manufactures of Remdesivir advised to display on their website, details of their stockists/distributors to facilitate acces […]
10
No lockdown in MP, only ‘corona curfew’: Chouhan | Health
[…] We have received 4,000 injections of Remdesivir (the key anti-viral drug) and would be getting 5,000 more today […]
0
India Bans Export Of Anti-Viral Drug Remdesivir Amid Surge In Covid Cases
[…] In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] To ensure more people can get Remdesivir, the government said manufactures of Remdesivir have been asked to show on their website the details of their stockists and distributors […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir,” the government said. The National Clinical Management Protocol for COVID-19 lists Remdesivir as an investigational therapy, where informed and shared decision making is essential […]
14
Remdesivir injections and Favipiravir tablets vanish from UP’s Prayagraj medicine shops | Allahabad News
dlsnewsindia.com – Today
PRAYAGRAJ: The Remdesivir injection and Favipiravir tablets seem to have vanished from the city-based medicine market wit […] at Leader road dealing wholesale medicine market claimed that there was an acute shortage of Remdesivir injection and Favipiravir tablets […] UP Chemist & Druggist Federation admitted to TOI that there has been an acute shortage of Remdesivir injection and Favipiravir tablets in markets and we have been demanding from concerne […] “ I have made calls to my relatives to arrange Remdesivir injection after seeing its acute crisis in city” said Ashutosh who arrived Leader road medicin […]
0
NEWS HIGHLIGHTS FROM WESTERN REGION AT 5 pm. | Law-Order
[…] BOM2 MH-REMDESIVIR-CONTROL ROOMS Maha to set up control rooms for smooth supply of Remdesivir Mumbai: The Maharashtra government has decided to set up district-level control rooms to ensur […] government has decided to set up district-level control rooms to ensure smooth supply of Remdesivir injections and prevent hoarding and black-marketing of the drug, officials said on Sunday […]
0
Coronavirus update: Latest Covid-19 vaccine and world news
[…] India has banned the export of anti-viral drug remdesivir and its active pharmaceutical ingredients following a rise in coronavirus cases, a statement fro […] The ban would apply to Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) until the Covid-19 situation in the country improves, th […] ministry said, adding that this rise has led to a sudden spike in demand for the anti-viral drug remdesivir and its active pharmaceutical ingredients used in the treatment of coronavirus patients […]
13
Business & Financial News, U.S & International Breaking News | Reuters
[…] Carnival-loving, eloquent Soeder wants to be Germany’s first Bavarian chancellor 2h ago India bans Remdesivir exports as coronavirus rages on; rallies continue 2h ago Pacific island devotees of Prince Phili […]
7K
AAP slams BJP’s ‘free Remdesivir distribution’ in Surat; Guj CM says ‘not from govt stock’
Last Updated: 11th April, 2021 16:37 IST AAP Slams BJP’s ‘free Remdesivir Distribution’ In Surat; Guj CM Says ‘not From Govt Stock’ Slamming BJP’s Gujarat unit over Remdesivir injection hoarding, AAP said that the BJP had taken PM Modi’s message of  “converting disasters o […] Currently, Gujarat’s neighbouring state Maharashtra too is facing an acute Remdesivir shortage. READ | Maharashtra to set up control rooms for smooth supply of Remdesivir amid COVID crisis “About Surat, C R Paatil has arranged for 5,000 Remdesivir injections […]
3
FREE Coronavirus Awareness Training – Free E-Learning Course
[…] trials are looking at the potential use of two HIV drugs as well as another antiviral called Remdesivir that was developed to tackle haemorrhagic fevers including Ebola […]

AstraZeneca Battles Supply Chain Issues, Denies Claims Its Covid-19 Vaccine Is Largely Ineffective In Seniors

Pharma giant AstraZeneca could face strict new export rules from the European Union that could restrict supply of its Covid-19 vaccine outside the bloc, as officials pressure the company to explain production shortfalls, while the company denies claims in German media that its vaccine is mostly ineffective in seniors.

Key Facts

Citing government sources, two German papers reported Monday that the efficacy of the vaccine AstraZeneca developed with the University of Oxford was “less than 10%” and 8% in those over 65.  

AstraZeneca said the claims are “completely incorrect” and go against published data from its clinical trials which showed a significant response in over-65s..

PROMOTED Mitsubishi Heavy Industries BrandVoice | Paid Program Oil & Gas Outlook – Embracing Change From Now To 2040 Grads of Life BrandVoice | Paid Program 3 Takeaways For Business Leaders Amid New Corporate Commitments UNICEF USA BrandVoice | Paid Program UNICEF Launches Online Tool Tracking COVID-19 Vaccine Market

Oxford University , which developed the vaccine with AstraZeneca, told the Financial Times there is “no basis for the claims of very low efficacy.”

The German health ministry also rejected the reports Tuesday, suggesting that the newspapers had got confused with the statistics. 

The confusion comes as tensions between AstraZeneca and the European Union soar to new levels, with the bloc furious at the company’s apparent inability or refusal to explain why it cannot honor its agreements and threatening to introduce new export rules for vaccines leaving the Union. 

Forbes has contacted  AstraZeneca to find out whether its supply chain issues and export rules could threaten vaccine supply to other parts of the world.

Key Background

On Friday, AstraZeneca informed Brussels that production issues meant it would be unable to honor its contractual commitments to provide doses to the EU. The vaccine is expected to be approved shortly and the delays mark another setback for the bloc’s vaccination efforts, which are already being hampered by a temporary reduction in deliveries from Pfizer while it makes changes to its production site.  

Chief Critic 

The EU stopped short of directly accusing AstraZeneca of reneging on its contracts in order to sell doses elsewhere, but said: “The European Union wants to know exactly which doses have been produced by AstraZeneca and where exactly so far and if or to whom they have been delivered,” Stella Kyriakides, the European Commissioner for Health and Food Safety, said in a statement.

Later, Kyriakides tweeted that discussions with the pharma giant “resulted in dissatisfaction” and there was a “lack of clarity and insufficient explanations.

What To Watch For

The EU may follow through on its threat to implement new vaccine export rules. This would require companies to seek permission before exporting internationally.   

Big Number 

31 million. This is how many doses the bloc is now expecting before the end of March, an EU official told Reuters. That amounts to a 60% cut.

Further Reading

Enraged at AstraZeneca over shortfall, EU calls for vaccine export controls (Politico)

AstraZeneca: German reports on low efficacy on over-65s ‘completely incorrect’ (DW)

Full coverage and live updates on the CoronavirusFollow me on Twitter. Send me a secure tip

Robert Hart

Robert Hart

I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at rhart@forbes.com

.

CNBC Television

AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority (BARDA) to develop a coronavirus vaccine from the University of Oxford. Pascal Soriot, CEO of AstraZeneca, joins “Squawk Box” and CNBC’s Meg Tirrell to discuss the company’s efforts to develop a Covid-19 vaccine. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2JdMwO7​ » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision​ » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC​ » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic​ Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/​ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC​ Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC​ Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC​ Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

More Contents:

Island View Dining Room January Specials Dining Offers http://www.grandportage.com – Today[…] 99 +TAX Portage Players Club member $15.99 + TAX Non – Portage Players Club member Breaded Chicken stuffed with broccoli and cheese on wild rice […] 99 +TAX Portage Players Club member $18.99 + TAX Non – Portage Players Club member Served with choice of potato and veggie of the day […] 99 +TAX Portage Players Club member $18.99 + TAX Non – Portage Players Club member Served with choice of potato and veggie of the day […]N/A

Fabric Canvas Loafers Walk Men’s Casual Shoes http://www.touchy-style.com – Today[…] 66 Tax included […]N/A

Pet Beds Sleep Warm Soft Sofas Puppy Blanket Chair Pad Floral Print Mu – zotmo.com – TodayPet Beds Sleep Warm Soft Sofas Puppy Blanket Chair Pad Floral Print Multifunction Dog Cat Mats Pet Car Seat Cover Sofa Mats Regular price €34,66 Tax included. Shipping calculated at checkout. ADD TO CART Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest Brand Name: Vitorhytech Wash Style: Hand Wash Feature: Breathable Pattern: Print Model Number: CW0317-01 Item Type: Beds & Sofas Type: Dogs Material: 100% Cotton Weight: 920g0

CrossCountry Mortgage to get $1.1M in job-creation tax credits for Cleveland HQ project http://www.bizjournals.com – Today0

How to Report Contributions From Fundraising Events to the IRS blog.expresstaxexempt.com – Today[…] complete this section by checking the boxes to select the fundraising methods you used during the tax year […] The IRS recommends e-filing for 990 series forms and even requires it for many tax-exempt organizations […]0

Cat Sunny Seat Window Mount Pet Cat Hammock Comfortable Cat Pet Bed Cu – zotmo.com – TodayCat Sunny Seat Window Mount Pet Cat Hammock Comfortable Cat Pet Bed Cute Pet Hanging Beds Bearing 20kg Regular price €20,68 Tax included. Shipping calculated at checkout. ADD TO CART Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest Origin: CN(Origin) Feature: Eco-Friendly Type: cats Material: Oxford Farbric Type: Cats model number: dp025 Unit Type: piece Package Weight: 0.625kg (1.38lb.) Package Size: 20cm x 20cm x 20cm (7.87in x 7.87in x 7.87in)0

Soft Pet Dog Cat Winter Warm Blanket Bed Mats Pads Comfortable Puppy K – zotmo.com – TodaySoft Pet Dog Cat Winter Warm Blanket Bed Mats Pads Comfortable Puppy Kitten Sofa Beds Cushion Slipcover Keep Warm Sleeping Cover Regular price €20,95 Tax included. Shipping calculated at checkout. ADD TO CART Wash Style: Mechanical Wash Feature: Breathable Pattern: Print Model Number: Pet Blanket Item Type: Bed Blankets Material: Other Weight: 180g Type: Dog Blanket Color: As show Size: S, M, L, XLN/A

SBA Illinois District Office Events http://www.eventbrite.com – Today[…] & Southern Illinois: Marketing & Selling to the Federal Government MULTIPLE DATES SBA Loans and IRS Tax Implications for Small Businesses SBA Loans and IRS Tax Implications for Small Businesses MULTIPLE DATES Central & Southern Illinois SBA Loan Clinic […]1

Talon Metals shares up on drill results at Tamarack http://www.mining.com – Today[…] 33 million and an after-tax payback of 2 […] , forecast an after-tax net present value of $291 million, at a 7% discount rate, and an internal rate of return of 36% […]0

In conversation with Wendy Walton: Insights and inspirations from an incredible career app.livestorm.co – Today[…] at BDO as a school leaver trainee, Wendy has built a successful career at BDO and is now a Senior Tax Partner […]0

Committee Works Towards Codifying Faster Ad Valorem Tax Collection System | Wyoming Public Media http://www.wyomingpublicmedia.org – Today[…] Committee passed two bills that take different approaches to transitioning to a monthly ad valorem tax for the mining industry […] The lag has resulted in every county in the state missing out on some tax revenue with mineral-rich counties missing out on in the tens of millions, according to the Wyoming […] the last legislative session, lawmakers passed a bill approving the shift to a monthly ad valorem tax collection system […]4

Final Countdown! Procrastinator’s CEU Marathon Happening Now myemail.constantcontact.com – Today[…] 5 hours Tax Planning and Bookkeeping, by David Hall NCRA-approved CEUs:  Total of 0 […]0

Why don’t we get the pharmaceutical industry we deserve? And what we can do about it http://www.lse.ac.uk – Today[…] her scholarly career in Queen Mary as the Herchel Smith Research Fellow followed by the FT Law & Tax Fellowship, before becoming a tenured lecturer in 2001 […]N/A

HOT JOBS & COOL JOBS: BOOKKEEPER GROWING COMPANY SAN ANTONIO TX USA http://www.e-physician.info – Today[…] Apply Now>> 5 Tax Senior Associate San Antonio, TX, USA … growing firm is looking for a detail-oriented Tax Associate to provide tax preparation, bookkeeping  […]  growing, and cutting-edge accounting and tax practice: Responsibilities: – Expense and income  […]0

adidas Anderlecht 1994-1995 Home Shirt – USED Condition (Great) – Size XL http://www.subsidesports.com – Today[…] Tax: £99.99 Incl. Tax: £119 […]0

9 times renting is smarter than buying a home, according to experts http://www.advisorstream.com – Today[…] ” Keep in mind that moving out too soon could also result in tax penalties depending on where you live […] You might change careers Unless you want to deal with potential tax penalties, investing in a home locks you down in one place — which means you may not be able t […]0

A1 Legal Co., Ltd | Luxury marine lifestyle directory platf http://www.marineluxurylifestyle.easybranches.com – Today[…] in providing business services including company registration, visas, work permits and accounting & tax […]0

TurboTax® #1 Best-Selling Tax Software, Taxes Done Right turbotax.intuit.com – Today[…] as requested through our Audit Support Center for returns filed with TurboTax for the current tax year (2020) and the past two tax years (2019, 2018). If we are not able to connect you to one of our tax professionals, we will refund the applicable TurboTax federal and/or state purchase price paid […] Tax Advice, Expert Review and TurboTax Live: Access to tax advice and Expert Review (the ability to have a Tax Expert review and/or sign your tax return) is included with TurboTax Live or as an upgrade from another version, and available through […]2

Rethinking value-added tax (VAT) to focus on environmental damage and sustainability ec.europa.eu – Today4TurboTax — http://www.dcfcu.org – TodayTURBOTAX Get Your Maximum Refund and Special Savings on TurboTax Tax time doesn’t have to be stressful!  With TurboTax, you’ll get your biggest possible refund fast and […] PLUS, credit union members save up to $15 on TurboTax federal products, all through tax season. TurboTax makes it easy to find the best solution for your unique tax situation […]0Waist Trainer – fitzone.shop – Today[…] 80 Tax included […]0

London, SW9 9HX | Investment Property for Sale | VES-SW9-005 http://www.vestaproperty.com – Today[…] rental income: £53,640 Tenants are paying all bills themselves including gas, electricity, council tax, water, TV licence, internet, fortnightly cleaner Bills are estimated to come to £6,015 per yea […]1

Boston developer’s request for $25M tax break denied in Georgia http://www.bizjournals.com – TodayN/A

Martin Hood to Open New Location in Peoria Heights http://www.prnewswire.com – Today[…] a new office location in Peoria Heights, Martin Hood looks to extend their individual and business tax, audit, and accounting services to a larger client base throughout Central Illinois […] Both awards were in 2019 and rated Martin Hood as number one in Tax Preparation and Accounting Services […]0

OTC Dynamics | $QUMU Qumu Reports Preliminary Fourth Quarter and 2020 Financial Results http://www.otcdynamics.com – Today[…] ) $ (1,671 ) $ (9,535 ) $ (9,275 ) $ (6,443 ) Interest expense, net 44 29 100 82 67 754 Income tax benefit (35 ) (50 ) (61 ) (182 ) (197 ) (194 ) Depreciation and amortization expense 307 297 35 […]1

Crwe World | Qumu Reports Preliminary Fourth Quarter and 2020 Financial Results crweworld.com – Today[…] ) $ (1,671 ) $ (9,535 ) $ (9,275 ) $ (6,443 ) Interest expense, net   44   29 100 82 67 754 Income tax benefit   (35 ) (50 ) (61 ) (182 ) (197 ) (194 ) Depreciation and amortization expense   307   29 […]

%d bloggers like this: